Skip to main content
# Title Department Research Member Research Year
681 Risk-Adapted, Combined-Modality Therapy for
Unfavorable Pediatric Hodgkin Lymphom
Department of Clinical Pathology Dr. Samar Muhammad mansour 2018
682 Author Correction: Strong associations between chromosomal aberrations in blood lymphocytes and the risk of urothelial and squamous cell carcinoma of the bladder. Department of Biostatistics and Cancer Epidemiology Nabiel Nazmi Hanna Mikhail 2018
683 Comparison of nebulised dexmedetomidine,
ketamine, or midazolam for premedication in
preschool children undergoing bone marrow biopsy
Department of Anesthesia, Intensive care and Pain management Dr. Shereen Mamdoh Mohamed kamal 2018
684 Effect of Dexmedetomidine Added to Modified Pectoral Block on Postoperative Pain and Stress
Response in Patient Undergoing Modified Radical Mastectomy
Department of Anesthesia, Intensive care and Pain management Prof. Sahar Abdel Baky Mohamed Ahmad 2018
685 Adjuvant Chemotherapy in High Risk Colon Cancer Standard FOLFOX or XELOX versus Short Duration of XELOX Department of Medical Oncology Dr. Mayada Fawzy Sedik Farghaly 2018
686 HCMV Among Pediatrics Acute Lymphoblastic Leukemia Patients in South Egypt Cancer Institute Department of Cancer Biology Dr. Mohammed Helmy Abdelhameed Maher 2018
687 Risk-Adapted, Combined-Modality Therapy for
Unfavorable Pediatric Hodgkin Lymphom
Department of Pathology Dr. Tarek Mohamed Abdel Moneim Mohamed Elsaba Ahmed 2018
688 Efficacy of 8 Gy Single Fraction Palliative Radiation Therapy in Painful Bone Metastases: A Single Institution Experience Department of Radiotherapy and Nuclear medicine Dr. Moamen Mohamed Omran Moustafa Aly 2018
689 Enhanced Recovery After Surgery: A Better Protocol for Better
Outcomes.
Department of Anesthesia, Intensive care and Pain management Ahmed ahmed ibrahem ahmed 2018
690 1. Concurrent Use of Capecitabine with Adjuvant
Radiotherapy in the Treatment of Patients with Breast
Cancer
Department of Radiotherapy and Nuclear medicine Dr. Mona Mahmoud Sayed 2018